TUXARIN
Dead / Abandoned — Abandoned — failure to respond (as of 30 Dec 2022)
What this means for you
This application is over — abandoned 19 Dec 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97027082
- Mark type
- Stylized text
- Filed
- 14 Sept 2021
- Abandoned
- 19 Dec 2022
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of coughs and colds; Pharmaceutical preparations for treating allergic rhinitis; Pharmaceutical preparations for treating allergies
Owner
- MainPointe Pharmaceuticals, LLC, Louisville, KY, US
Prosecution history
- 30 Dec 2022 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 30 Dec 2022 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 30 Dec 2022 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 17 Jun 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 17 Jun 2022 — NON-FINAL ACTION E-MAILED
- 17 Jun 2022 — NON-FINAL ACTION WRITTEN
- 16 Jun 2022 — ASSIGNED TO EXAMINER
- 20 Oct 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 17 Sept 2021 — NEW APPLICATION ENTERED